Compounds and Compositions for Modulating Lipid Levels and Methods of Preparing Same
    1.
    发明申请
    Compounds and Compositions for Modulating Lipid Levels and Methods of Preparing Same 审中-公开
    用于调节脂质含量的化合物和组合物及其制备方法

    公开(公告)号:US20110009628A1

    公开(公告)日:2011-01-13

    申请号:US12832852

    申请日:2010-07-08

    摘要: The present technology relates to compounds of Formulas I-VI and methods of making and using such compounds. Methods of use include prevention and treatment of hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, hepatic steatosis, and metabolic syndrome. Compounds disclosed herein also increase HDL-C, lower total cholesterol, LDL-cholesterol, and triglycerides and increase hepatic LDL receptor expression, inhibit PCSK9 expression, and activate AMP-activated protein kinase.

    摘要翻译: 本技术涉及式I-VI的化合物及其制备和使用方法。 使用方法包括预防和治疗高脂血症,高胆固醇血症,高甘油三酯血症,肝脂肪变性和代谢综合征。 本文公开的化合物还增加HDL-C,降低总胆固醇,低密度脂蛋白胆固醇和甘油三酸酯,并增加肝脏LDL受体表达,抑制PCSK9表达,并激活AMP激活的蛋白激酶。

    COMPOUNDS, COMPOSITIONS AND METHODS FOR REDUCING LIPID LEVELS
    2.
    发明申请
    COMPOUNDS, COMPOSITIONS AND METHODS FOR REDUCING LIPID LEVELS 有权
    化合物,组合物和减少脂质水平的方法

    公开(公告)号:US20120004223A1

    公开(公告)日:2012-01-05

    申请号:US13141310

    申请日:2009-12-22

    CPC分类号: C07D455/03 C07D495/04

    摘要: The present technology relates to compounds of Formulas (V) and (VI) and methods of making and using such compounds. Methods of use include prevention and treatment of hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, hepatic steatosis, and metabolic syndrome. Compounds disclosed herein also lower total cholesterol, LDL-cholesterol, and triglycerides and increase hepatic LDL receptor expression, inhibit PCSK9 expression, and activate AMP-activated protein kinase.

    摘要翻译: 本技术涉及式(V)和(VI)的化合物及其制备和使用方法。 使用方法包括预防和治疗高脂血症,高胆固醇血症,高甘油三酯血症,肝脂肪变性和代谢综合征。 本文公开的化合物还降低总胆固醇,低密度脂蛋白胆固醇和甘油三酸酯,并增加肝脏LDL受体表达,抑制PCSK9表达,并激活AMP激活的蛋白激酶。

    Compounds, compositions and methods for reducing lipid levels
    3.
    发明授权
    Compounds, compositions and methods for reducing lipid levels 有权
    用于降低脂质水平的化合物,组合物和方法

    公开(公告)号:US08710071B2

    公开(公告)日:2014-04-29

    申请号:US13141310

    申请日:2009-12-22

    IPC分类号: A61K31/4745 C07D471/06

    CPC分类号: C07D455/03 C07D495/04

    摘要: The present technology relates to compounds of Formulas (V) and methods of making and using such compounds. Methods of use include prevention and treatment of hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, hepatic steatosis, and metabolic syndrome. Compounds disclosed herein also lower total cholesterol, LDL-cholesterol, and triglycerides and increase hepatic LDL receptor expression, inhibit PCSK9 expression, and activate AMP-activated protein kinase.

    摘要翻译: 本技术涉及式(V)的化合物和制备和使用这些化合物的方法。 使用方法包括预防和治疗高脂血症,高胆固醇血症,高甘油三酯血症,肝脂肪变性和代谢综合征。 本文公开的化合物还降低总胆固醇,低密度脂蛋白胆固醇和甘油三酸酯,并增加肝脏LDL受体表达,抑制PCSK9表达,并激活AMP激活的蛋白激酶。